NASDAQ
Cidara Therapeutics, Inc. (CDTX) has a current ratio of 4.25x as of Monday, May 25, 2026. This represents a 204.71% increase compared to its 12-month average of 1.40x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.